In addition to harmless commensal species, Neisseria genus encompasses two pathogenic species, N. meningitidis (the meningococcus) and N. gonorrhoeae (the gonococcus), which are responsible for meningitis and genital tract infections, respectively. Since the publication of the first Neisseria genome in 2000, the presence of several genomic islands (GI) comprising maf genes has been intriguing. These GIs account for approximately 2% of the genome of the pathogenic Neisseria species and the function of the proteins encoded by maf genes remained unknown. We showed that maf genes encode a functional toxin-immunity system where MafB is a toxin neutralized by an immunity protein named MafI. A strain can harbor several MafB/MafI modules with distinct toxic activities. MafB toxins are polymorphic toxins with a conserved Nterminal region and a variable C-terminal region. MafB N-terminal regions consist of a signal peptide and a domain named DUF1020 that is only found in the genus Neisseria. MafB C-terminal regions are highly polymorphic and encode toxic activities. We evidenced the presence of MafB in the culture supernatant of meningococcal cells and we observed a competitive advantage for a strain overexpressing a MafB toxin. Therefore, we characterized a highly variable family of toxin-immunity modules found in multiple loci in pathogenic Neisseria species.
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In silico analysis, recently revealed that polymorphic toxinimmunity systems are widespread in both Gram-negative and -positive bacteria. In these systems, secreted multidomain toxins are neutralized by specific cognate antitoxin named immunity protein. The N-terminal region of the toxin is related to trafficking mode whereas the Cterminal region is hypervariable and carries the toxic activity. Toxin and immunity genes are organized in an operon. Loci also contain cassettes encoding alternative C-termini that could promote diversity of toxic activities through a process of genetic recombination. The polymorphic toxin systems are typically encoded on hypervariable chromosomal islands with characteristics of horizontal gene transfer. These systems are primarily involved in interbacterial competition. For instance, CDI systems, which are a group of polymorphic toxin systems, have been shown to be involved in a contact-dependent inhibition of growth in several Gram-negative bacteria.
N. meningitidis is commonly found in the nasopharynx of healthy individuals. In some yet poorly characterized circumstances, the meningococcus can cross the nasopharyngeal mucosal epithelium and cause sepsis or meningitis. N. gonorrhoeae is a common cause of sexually transmitted infection. The availability of complete genome sequences for several meningococcal, gonococcal and non-pathogenic species strains enabled their comparison to identify relevant genetic variations.
We studied genomic islands containing genes of the multiple adhesin family (maf). We identified 3 maf genomic islands (MGI-1 to 3) located at the same genomic position in meningococcus and in gonococcus. We also identified 2 additional MGIs (MGI-4 and 5) in gonococcal strains. In contrast, these MGIs were virtually absent in commensal species. A MGI is typified by at least one module of two genes: mafB encoding a toxin and mafI encoding an immunity protein. MafB proteins exhibit a N-terminal conserved domain of unknown function named DUF1020 (or PF06255 in PFAM Database), which is restricted to Neisseria genus, and a C-terminal (CT) hypervariable region. Based on the amino acids alignment of the N-terminal region of MafB proteins, we distinguished 3 classes of MafB. In addition to the mafB-mafI module, a mafA gene is frequently found immediately upstream of mafB. The product of mafA gene is predicted to be an outer membrane exposed lipoprotein. It has been shown that gonococcal MafA binds to glycolipids but its precise function remains elusive. Like the DUF1020 domain, mafA genes are restricted to the Neisseria genus.
To assess the putative function of mafB-mafI modules, we expressed four predicted MafB toxins from meningococcal strain 8013 in E. coli. Induction of the expression of two MafB proteins was highly toxic for E. coli both on Luria-Bertani (LB) agar plates and in liquid LB culture. By cloning only the DNA region encoding the C-terminal domain or the N-terminal domain of MafB toxins, we demonstrated that the toxicity of MafB relies in its C-terminal domain. We showed that the protein encoded by the mafI gene located immediately downstream of mafB was indeed an immunity protein, able to neutralize its cognate toxin when both proteins are co-expressed. In contrast, there is no cross-protection conferred by a non-cognate immunity protein. We were also able to co-purify a MafB toxin with its cognate immunity protein, which suggests that MafI is likely to inhibit MafB toxicity by a direct interaction. Thus, we have demonstrated that two mafB-mafI modules from strain 8013 (mafBI MGI-1NEM8013 and mafBI MGI-3NEM8013 ) are functional toxin-immunity systems when expressed in E. coli. Then, we assessed the toxicity of MafB proteins in Neisseria. We evidenced that it was impossible to delete the immunity gene of three of the four mafB genes of strain 8013 and it was also impossible to insert an ectopic copy of the same three mafB genes in the 8013 genome. Thus, three MafB proteins (MafB MGI-1NEM8013 , MafB1 and MafB MGI-3NEM8013 ) are toxic in their original Neisseria strain.
We focused on one MafB toxin from strain 8013 (Maf-B MGI-1NEM8013 ) that was in silico predicted to have a ribonuclease activity cleaving RNA at uridylates (EndoU ribonuclease). We purified this protein and incubated it with a synthetic RNA. A cleavage of this RNA only when it contains uridylates (U) was observed. On the other hand, no cleavage was observed when the cognate purified immunity protein was added to the reaction. Therefore, we characterized the first bacterial EndoU ribonuclease.
Consistent with the fact that MafB sequences contain a signal peptide (SP), we were able to detect MafB in culture supernatants. In addition, we showed that this secretion requires the N-terminal signal peptide. Altogether these data demonstrate that MafB are secreted toxins.
Since other polymorphic toxins have been involved in interbacterial competition, we searched for a role of MafB in competition assays. We used strain 8013 and tested the impact of the overexpression of the four MafB proteins in competition assays. We evidenced a significant competitive advantage for the isolate overexpressing MafB1 MGI-2NEM8013 . This advantage was no longer observed when target cells overexpressed the cognate immunity MafI1 MGI-2NEM8013 . This suggests that MafB1 MGI-2NEM8013 could be employed by strain 8013 to outcompete strains that do not possess the cognate immunity. 
